1. Systemic Immune-Inflammation Index Is a Prognostic Factor for Breast Cancer Patients After Curative Resection
    Wen Li et al, 2021, Frontiers in Oncology CrossRef
  2. Systemic Inflammatory Response as a Prognostic Factor in Breast Cancer. Part II. Hematological Markers of Inflammation
    Natalia S. Sergeeva et al, 2023, Annals of the Russian academy of medical sciences CrossRef
  3. Hematological ratios as prognostic indicators in patients with triple-negative breast cancer in southern Brazil
    Camila Macedo Boaro et al, 2022, Mastology CrossRef
  4. Development and validation of a nomogram for predicting recurrence-free survival in endometrial cancer: a multicenter study
    Yinuo Li et al, 2023, Scientific Reports CrossRef
  5. Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
    Qian-Qian Liao et al, 2024, International Journal of Chronic Obstructive Pulmonary Disease CrossRef
  6. A Novel Inflammatory and Nutritional Prognostic Scoring System for Nonpathological Complete Response Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
    Cong Jiang et al, 2022, Disease Markers CrossRef
  7. A real‐world study of immune checkpoint inhibitors in advanced triple‐negative breast cancer
    Zheng Zhang et al, 2023, Cancer Innovation CrossRef
  8. Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients
    Sejdi Lusho et al, 2021, Frontiers in Oncology CrossRef
  9. Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers
    Céline Blaye et al, 2022, Frontiers in Immunology CrossRef
  10. Association of a High Neutrophil-to-Lymphocyte Ratio with Hyperdense Artery Sign and Unfavorable Short-Term Outcomes in Patients with Acute Ischemic Stroke
    Shinn-Kuang Lin et al, 2021, Journal of Inflammation Research CrossRef